This content is machine translated Triple-negative stage I-III breast carcinoma Attack on an untouchable While targeted therapies are on the rise, there are still tumors that cannot (yet) benefit from this development. One such is triple-negative breast carcinoma. But even here, far from targeted…
View Post 23 min This content is machine translated Rheumatism and cancer Effects of cancer on rheumatoid arthritis therapy Immunomodulatory and immunosuppressive therapies in cancer patients may promote progression or recurrence of malignant disease. However, the various substances differ with regard to this risk. In addition to the careful… CME-Test
View Post 4 min This content is machine translated Study Overview What’s new in the world of cardiology? Scientific research is constantly being pursued, enabling advances to be made time and again in the therapeutic management of cardiological diseases. The most interesting study results around pericarditis, chronic coronary…
View Post 1 min This content is machine translated Interdisciplinary therapy management Gynecologist and oncologist talking about ovarian cancer Although the prognosis for ovarian cancer patients has improved in recent years, it is still the most lethal gynecologic tumor [1, 2]. In a video interview, gynecologist Prof. Andreas Günthert,…
View Post 5 min This content is machine translated Non-resectable gastric carcinoma Immunotherapy on the rise The prognosis of advanced gastric carcinoma remains extremely unfavorable. Accordingly, new treatment approaches are urgently needed. Current evidence suggests that checkpoint inhibitor therapy may become more important in the near…
View Post 3 min This content is machine translated The somewhat different knowledge Where does the name “Pancoast tumor” actually come from? The clinical picture of Pancoast tumor is widely known. But where does the somewhat strange name actually come from? We got to the bottom of it.
View Post 6 min This content is machine translated Therapy of metastatic HER2-positive breast carcinoma Is a cure possible soon? In recent years, the prognosis of metastatic HER2-positive breast carcinoma has been significantly improved by the development of new agents such as the antibody-drug conjugate (ADC) trastuzumab-deruxtecan and the HER2-targeted…
View Post 10 min This content is machine translated Non-chemotherapy-induced neutropenia Isolated neutropenia: a clinical picture with many faces Neutropenia is a frequent guest in the practice as an independent clinical picture, but also as an accompanying symptom of many diseases and as an adverse drug reaction. The accompanying… CME-Test
View Post 10 min This content is machine translated Visceral Surgery Update - Part 2 Lower gastrointestinal tract and perioperative management Approximately 60 per 1000 population undergo abdominal surgery annually. The majority of patients are initially evaluated and triaged in the primary care physician’s office. Part 2 of the Visceral Surgery… CME-Test
View Post 5 min This content is machine translated Myelofibrosis Treatment in transition With the introduction of the Janus kinase (JAK) inhibitor ruxolitinib, therapy for myelofibrosis has changed dramatically in recent years. Nevertheless, further innovation is needed, especially in the second line. Promising…
View Post 5 min This content is machine translated Germ cell tumors of the testis Management of early stages: State of the art Although testicular cancer accounts for only 1% of oncologic disease in men, it is the most common cancer in boys. PD Dr. med. Richard Cathomas, Deputy Chief Physician at the…
